Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases

Annals of Oncology

Volumn 19, Issue 11, 2008, Pages 1829-1835

  Scheer, M G W ^a   Sloots, C E J ^a   Van der Wilt, G J ^a   Ruers, T J M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Chemotherapy; Colorectal cancer; Metastases; Surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; HUMAN; INTESTINAL BLEEDING; INTESTINE FISTULA; INTESTINE OBSTRUCTION; LIVER METASTASIS; LIVER SURGERY; LUNG METASTASIS; LUNG SURGERY; METASTASIS; OUTCOME ASSESSMENT; PATIENT CARE; PERITONEUM METASTASIS; PERITONITIS; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; SYSTEMATIC REVIEW; TUMOR LOCALIZATION;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING;

EID: 54949108656     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn398     Document Type: Review

References (24)

1. Mella J, Biffin A, Radcliffe AG et al. Population-based audit of oolorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit Br J Surg 1997; 84: 1731-1736.
2. Millikan KW, Staren ED, Doolas A. Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 1997; 77: 27-48.
3. Michel P, Roque I, Di FF et al. Colorectal cancer with non-resectable synchronous metastases: Should the primary tumor be resected? Gastroenterol Clin Biol 2004; 28: 434-437.
4. de GA, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
5. Douillard JY, Cunningham D, Roth AD et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal-cancer: A multicentre randomised trial. Lancet 2000; 355: 1041-1047.
6. Sarela A, O'Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001; 88: 163-164.
7. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
8. Sarela AI, Guthrie JA, Seymour MT et al. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001; 88: 1352-1356.
9. Benoist S, Pautrat K, Mitry E et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92: 1155-1160.
10. Scoggins CR, Meszoely IM, Blanke CD et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Onool 1999; 6: 651-657.
11. Ruo L, Gougoutas C, Paty PB et al. Elective bowel resection for incurable stage IV colorectal cancer: Prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196: 722-728.
12. Tebbutt NC, Norman AR, Cunningham D et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52: 568-573.
13. Muratore A, Zorzi D, Bouzari H et al. Asymptomatic colorectal cancer with unresectable liver metastases: Immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007; 14: 766-770.
14. Liu SK, Church JM, Lavery IC et al. Operation in patients with incurable colon cancer - is it worthwhile? Dis Colon Rectum 1997; 40: 11-14.
15. Makela J, Haukipuro K, Laitinen S et al. Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33: 846-850.
16. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981; 24: 355-360.
17. Law WL, Chan WF, Lee YM et al. Non-curative surgery for colorectal cancer: Critical appraisal of outcomes. Int J Colorectal Dis 2004; 19: 197-202.
18. Kuo LJ, Leu SY, Liu MC et al. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46: 1646-1652.
19. Okuyama K, Onoda S, Tohnosu N et al. The prognostic significance of resection of primary tumor in gastric and colorectal cancer patients with synchronous liver metastasis. Jpn J Surg 1988; 18: 7-17.
20. Mahteme H, Pahlman L, Glimelius B et al. Prognosis after surgery in patients with incurable rectal cancer: A population-based study. Br J Surg 1996; 83: 1116-1120.
21. Rosen SA, Buell JF, Yoshida A et al. Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 2000; 135: 530-534.
22. Nash GM, Saltz LB, Kemeny NE et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002; 9: 954-960.
23. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004; 240: 644-657.
24. Folprecht G, Grothey A, Alberts S et al. Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-1319.